🔎 Trials Near Me

Home › Mantle Cell Lymphoma › Texas › Houston

Pag-aaral pangklinika para sa Mantle Cell Lymphoma sa Houston, TX

Isang pag-aaral para sa Mantle Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Nagre-recruitPhase 1/2
  • Research Site, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06542250

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Nagre-recruitPhase 3
  • Md Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06742996

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Nagre-recruitPhase 1/2
  • Md Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05006716

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1
  • MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Nagre-recruitPhase 1/2
  • Research Site, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06564038

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Nagre-recruitPhase 1
  • The University of TX MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07424833

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2
  • The University of Texas MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1
  • MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

Nagre-recruitPhase 2
  • M D Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT05529069

Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
  • MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT06263491

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1
  • MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Nagre-recruitPhase 1
  • Oncology Consultants, Houston
  • University of Texas MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Houston
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Nagre-recruitPhase 2
  • M D Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 18, 2024 · NCT05910801

Pag-aaral para sa Mantle Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.